NEPHROCARE HEALTH SERV L (NEPHROPLUS) Share Price at fresh 52-week high
- September 11, 2026
- Posted by: Harsh Piplani
- Category: News
NEPHROCARE HEALTH SERV L Share Price is in focus after the stock touched a fresh 52-week high of Rs 774.85 and was last traded at Rs 771.35, up Rs 24 or 3.21% from the previous close of Rs 747.35. The company’s market capitalisation stood at Rs 7,372.48 Cr as of 11 September 2026 at 12:22 PM IST. According to latest Univest data, the move places NEPHROCARE HEALTH SERV L Stock News firmly in the day’s market discussion, with the fresh yearly high confirming a notable price event. The latest Univest figures confirm the price action, but they do not establish a company-specific catalyst.
For readers tracking NEPHROCARE HEALTH SERV L Share Price Today, the stock opened at Rs 745 and moved between Rs 733.8 and Rs 774.85 during the day so far. Turnover stood at Rs 2.34 Cr. The price also matched its 52-week peak at Rs 774.85, so the event is a fresh 52-week high rather than an all-time high. That distinction matters for NEPHROCARE HEALTH SERV L Stock News, NEPHROCARE HEALTH SERV L Share News and broader Share Market Today search intent.
NEPHROCARE HEALTH SERV L Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 771.35 |
| Previous Close | Rs 747.35 |
| Today's Move | +Rs 24 (+3.21%) |
| Open | Rs 745 |
| High | Rs 774.85 |
| Low | Rs 733.8 |
| Turnover | Rs 2.34 crore |
| Market Capitalisation | Rs 7,372.48 crore |
NEPHROCARE HEALTH SERV L (NEPHROPLUS) traded at Rs 771.35 versus the previous close of Rs 747.35, a rise of 3.21%. The stock opened at Rs 745, reached a high of Rs 774.85 and touched a low of Rs 733.8.
NEPHROCARE HEALTH SERV L Share Price Today reflects a session where the stock started at Rs 745, moved to a low of Rs 733.8, and touched Rs 774.85, which is also its fresh 52-week high. The last traded price of Rs 771.35 sits Rs 24 above the previous close of Rs 747.35, and the day change of 3.21% is a straightforward arithmetical readout of that move. Turnover of Rs 2.34 Cr provides a factual measure of traded value during the period.
What exactly happened today is simple and important for NEPHROCARE HEALTH SERV L Share Price watchers: the stock traded above its previous one-year peak and established a fresh 52-week high in ongoing market action. The price moved within a range of Rs 41.05 from low to high, and the current level remains close to the day’s peak. For those scanning Stocks in News, 52 Week High Stocks and Market Movers, this is the core event to note. The latest Univest figures confirm the price event, while not assigning a reason for it.
NEPHROCARE HEALTH SERV L (NEPHROPLUS) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 7,372.48 crore |
| P/E Ratio | 97.8x |
| P/B Ratio | 6.63x |
| ROE | 9.22% |
| ROCE | 16.18% |
| EPS | Rs 7.64 |
| Book Value Per Share | Rs 112.78 |
| Dividend Yield | 0% |
NEPHROCARE HEALTH SERV L (NEPHROPLUS) fundamental metrics show P/E 97.8x, P/B 6.63x, ROE 9.22%, ROCE 16.18%. These figures provide context only and are not a buy or sell signal.
NEPHROCARE HEALTH SERV L has a market capitalisation of Rs 7372.48 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 97.8x, P/B at 6.63x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 9.22% and ROCE of 16.18%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 7.64, book value per share of Rs 112.78, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 47.7x, median ROE of 13.39%, median ROCE of 15.83%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Hospital & Healthcare Services |
| Benchmark Scope | same industry |
| Company P/E Ratio | 97.8x |
| Benchmark Median P/E | 47.7x |
| Benchmark Average P/E | 100.68x |
| Benchmark P/E Range | 7.32x to 1,541.01x |
| Company P/B Ratio | 6.63x |
| Benchmark Median P/B | 3.82x |
| Company ROE | 9.22% |
| Benchmark Median ROE | 13.39% |
| Company ROCE | 16.18% |
| Benchmark Median ROCE | 15.83% |
| Company Market Capitalisation | Rs 7,372.48 crore |
| Benchmark Median Market Cap | Rs 520.87 crore |
NEPHROCARE HEALTH SERV L (NEPHROPLUS) is classified under sector: Healthcare and industry: Hospital & Healthcare Services.
NEPHROCARE HEALTH SERV L (NEPHROPLUS) has a P/E ratio of 97.8x, which is above the benchmark median of 47.7x, a difference of +105.03%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
NEPHROCARE HEALTH SERV L (NEPHROPLUS) has a ROE of 9.22%, which is below the benchmark median of 13.39%, a difference of -31.14%. NEPHROCARE HEALTH SERV L (NEPHROPLUS) has a ROCE of 16.18%, which is above the benchmark median of 15.83%, a difference of +2.21%.
Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Kovai Medical Center & Hospital Ltd. | KOVAI | 6,730.09 | 26.91 | 4.97 | 20.33 | 22.89 |
| Thyrocare Technologies Ltd. | THYROCARE | 9,034.22 | 50.33 | 14.1 | 29.05 | 38.3 |
| Jupiter Life Line Hospitals Ltd. | JLHL | 9,307.1 | 49.02 | 5.82 | 13.39 | 15.7 |
| Yatharth Hospital & Trauma Care Services Ltd. | YATHARTH | 9,531.85 | 52.01 | 5.16 | 10.06 | 13.3 |
| Artemis Medicare Services Ltd. | ARTEMISMED | 5,611.96 | 48.57 | 6.15 | 12.72 | 15.83 |
NEPHROCARE HEALTH SERV L (NEPHROPLUS) has a P/E ratio of 97.8x compared with the displayed peer median of 49.02x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 9.22% compares with a peer median of 13.39% across the companies shown in the table. ROCE stood at 16.18% versus the displayed peer median of 15.83%, providing a capital-efficiency comparison. NEPHROCARE HEALTH SERV L (NEPHROPLUS) has a market capitalisation of Rs 7,372.48 crore. Among the 5 peers shown, 3 have a larger market capitalisation.
Why Investors Are Watching NEPHROCARE HEALTH SERV L
- NEPHROCARE HEALTH SERV L Share Price touched a fresh 52-week high of Rs 774.85 and was last traded at Rs 771.35.
- The stock was up Rs 24, or 3.21%, versus the previous close of Rs 747.35.
- Market capitalisation stood at Rs 7,372.48 Cr, which is above the same-industry median of Rs 520.87 Cr.
- P/E of 97.8 and P/B of 6.63 both sit above the Healthcare benchmark medians of 47.7 and 3.82.
- ROE of 9.22% is below the sector median of 13.39%, while ROCE of 16.18% is slightly above the 15.83% median.
About NEPHROCARE HEALTH SERV L
NEPHROCARE HEALTH SERV L operates in the Healthcare sector and the Hospital & Healthcare Services industry. The listed company is followed as NEPHROPLUS on NSE and BSE market screens. For readers tracking NEPHROCARE HEALTH SERV L Share Price, the relevant business context is the sector classification, the industry group, and the latest company financial numbers provided alongside the market data. Univest tracks such company-level identifiers so that NEPHROCARE HEALTH SERV L Share Price Today, NEPHROCARE HEALTH SERV L News Today and broader stock analysis can be read in one place.
Frequently Asked Questions
What is NEPHROCARE HEALTH SERV L Share Price today?
Ans. NEPHROCARE HEALTH SERV L Share Price was Rs 771.35, up 3.21% from the previous close of Rs 747.35. The stock also touched Rs 774.85 during the ongoing market action, marking a fresh 52-week high.
Why did NEPHROCARE HEALTH SERV L touch a fresh 52-week high?
Ans. The latest Univest figures confirm that NEPHROCARE HEALTH SERV L touched Rs 774.85, its fresh 52-week high, but they do not establish a company-specific catalyst. The price event itself is the verified fact.
What was the day’s range for NEPHROCARE HEALTH SERV L Share Price?
Ans. The stock moved between Rs 733.8 and Rs 774.85 during the day. The low, open at Rs 745, and the touch of the 52-week peak together show the trading range so far.
How does NEPHROCARE HEALTH SERV L look on valuation?
Ans. NEPHROCARE HEALTH SERV L Share Price is backed by a P/E of 97.8 and P/B of 6.63. Both stand above the Healthcare benchmark medians of 47.7 and 3.82, which places valuation in context.
What do EPS and book value mean for NEPHROCARE HEALTH SERV L?
Ans. EPS is Rs 7.64 and book value is Rs 112.78. EPS shows earnings attributable to each share, while book value per share reflects accounting net worth per share for NEPHROCARE HEALTH SERV L Share Price readers.
Is NEPHROCARE HEALTH SERV L profitable in the latest company figures?
Ans.7 Cr in Mar 2026. Revenue was Rs 2,817.54 Cr and Rs 2,656.15 Cr in those periods.
How does NEPHROCARE HEALTH SERV L compare with Healthcare peers?
Ans. NEPHROCARE HEALTH SERV L Share Price trades with a higher P/E than the listed peers shown, while ROCE at 16.18% is close to Artemis and above Yatharth. Its market cap is Rs 7,372.48 Cr.
Should investors track NEPHROCARE HEALTH SERV L Share Price on Univest?
Ans. Investors can track NEPHROCARE HEALTH SERV L Share Price on Univest for live updates, 52-week levels, valuation ratios and sector comparison. That makes it easier to review NEPHROCARE HEALTH SERV L Stock News and related market facts.
Track NEPHROCARE HEALTH SERV L Share Price on Univest
Use NEPHROCARE HEALTH SERV L (NEPHROPLUS) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.
Track NEPHROCARE HEALTH SERV L Share Price on Univest for live price updates, 52-week levels, valuation ratios, financial results, company overview, and sector comparison. Univest also helps readers follow NEPHROCARE HEALTH SERV L Share Price Live, NEPHROCARE HEALTH SERV L Latest News, and NEPHROCARE HEALTH SERV L Share News with a structured view of the latest market facts.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
